Immunomedics Inc
IMMU
IMMU was delisted on the 22nd of October, 2020.
101 hedge funds and large institutions have $167M invested in Immunomedics Inc in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 29 increasing their positions, 33 reducing their positions, and 15 closing their positions.
92% more call options, than puts
Call options by funds: $6.99M | Put options by funds: $3.65M
39% more capital invested
Capital invested by funds: $120M → $167M (+$46.9M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
8% less funds holding
Funds holding: 110 → 101 (-9)
12% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 33
53% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JGC
J. Goldman & Co
New York
|
+$4.74M |
| 2 |
NC
Nexthera Capital
New York
|
+$3.53M |
| 3 |
Millennium Management
New York
|
+$2.85M |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$2.8M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$1.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$4.11M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
-$3.39M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.63M |
| 4 |
State Street
Boston,
Massachusetts
|
-$2.58M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$979K |
IMMU Hedge Fund Activity: Q3 2016 in Review
101 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q3 2016, worth a combined $167M — up 39% from $120M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of IMMU and 7 opened new positions — a net loss of 8 holders — while 33 trimmed existing stakes and 29 added.
The largest buyer was J. Goldman & Co, opening a new position worth an estimated $4.74M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $4.11M sold.
- 101 institutional investors held Immunomedics Inc (IMMU) as of Q3 2016, down from 110 in Q2 2016.
- Funds reported $167M of Immunomedics Inc stock for Q3 2016, up 39% quarter-over-quarter.
- 7 funds opened new Immunomedics Inc positions in Q3 2016 and 15 closed out, a net change of -8 holders.
- The largest Immunomedics Inc buyer in Q3 2016 was J. Goldman & Co, an estimated $4.74M added.
- The largest Immunomedics Inc seller in Q3 2016 was Renaissance Technologies, an estimated $4.11M sold.
Based on aggregated 13F filings for Q3 2016.